Clinicopathologic Conference, Systemic Primary Amyloidosis
NEJM 384:363-372, Case 3-2021, 2021
Giant-cell Arteritis
NEJM 347:272-278, Case 23-2002, 2002
Permanent Visual Loss and Cerebrovascular Accidents in Giant Cell Arteritis: Predictors and Response to Treatment
Arthritis Rheum 41:1497-1504, Gonzalez-Gay,M.,et al, 1998
Carbamazepine Side Effects in Children and Adults
Pellock. J. M. , Epilepsia 28:S64-S707., , 1987
Cholesterol Crystal Embolization:A Review of 221 Cases in the English Literature
Angiology 38:769-784, Fine,M.J.,et al, 1987
Clinicopatholigical Conference, Plasmodium Falciparum Malaria
NEJM 309:549-556, Case 4-2024, 2024
Clinicopathologic Conference, Acute human immunodeficiency virus type 1
NEJM 385:641-648, Case 24-2021, 2021
Congenital Cytomegalovirus Infection
BMJ 373:m1212, Pesch, M.H.,et al, 2021
Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy
NEJM 381:275-283, Case 22-2019, 2019
Clinicopathologic Conference, Atypical Immunoblastic Reaction that was consistent with Primary Epstein-Barr virus Infecton
NEJM 377:677-688, Case 25-2017, 2017
Clinical Findings and Diagnosis in Human Granulocytic Anaplasmosis: A Case Series from Massachusetts
Mayo Clin Proc 87:233-239, Weil, A.A.,et al, 2012
Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011
Infectious Mononucleosis in Adults and Adolescents
UpToDate, May, Aronson,M.D. & Auwaerter,P.G., 2011
Liver Involvement in Celiac Disease
Minerva Med 99:595-604, Rubio-Tapia,A. & Murray,J.A., 2008
Direct Thrombin Inhibition and Stroke Prevention in Elderly Patients With Atrial Fibrillation: Experience From the SPORTIF III and V Trial
Stroke 38:2965-2971, Ford,G.A.,et al, 2007
Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005
Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial
Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
A Case of Acute Monocytic Ehrlichiosis with Prominent Neurologic Signs
Neurol 48:1619-1623, Grant,A.C.,et al, 1997
Antibiotic Treatment for Giant-Cell Arteritis
Lancet 348:1630, Fontana,P.E.,et al, 1996
Clinicopath Conf
Polyarteritis Nodosa, with Neuropathy, Case 40-1994, NEJM 331:1293-130094., , 1994
Ticlopidine
Editorial, Lancet 337:459-4601991., , 1991
Eosinophilia-Myalgia Syndrome, A Clinical Case Series of 21 Patients
Arch Int Med 151:533-537, Philen,R.M.,et al, 1991
Wilson Disease:Clinical Presentation, Treatment, and Survival
Ann Int Med 115:720-726, Stremmel,W.,et al, 1991
Clinicopath Conf
Sarcoidosis of CNS and Mediastinal Lymph Nodes, Case Record 6-1990, NEJM 322:388-397990., , 1990
Human Ehrlichiosis Associated with Cerebrospinal Fluid Pleocytosis:A Case Presentation
Am J Med 87:677-678, Dimmitt,D.C.,et al, 1989
Human Leptospirosis-A Review of 50 Cases
Infection 17:10-14, Lecour,H.,et al, 1989